The Week

ReposiTrak fell 1.7% this week to $8.09, underperforming the S&P 500, which slipped 0.27%, by about 1.43 percentage points. The weekly range was 9.84%. Trading was choppy with an upward drift that faded: Monday opened near $8.23 and closed at $8.20; Tuesday dipped to $7.66 early then recovered to $8.16; Wednesday rallied on heavier volume to $8.37; Thursday touched the weekly high of $8.47 and closed at $8.35; Friday gave back gains to end at $8.09. Average daily volume of 95,452 shares was 55.37% above the 60-day median.

Key Events

The week centred on fiscal Q4 and full-year FY2026 results. The company appeared on the 28 September earnings schedule and reported on 29 September before the open: Q4 GAAP net income rose 16% to $2.1 million, EPS grew 20%, but quarterly revenue slipped to $5.6 million year over year. Full-year revenue came in at $23.29 million with EPS of $0.39. The 10-K summary reiterated the pattern of improving profit and declining revenue. On 30 September the earnings call highlighted rising profits and new growth engines, an effort to offset the softer top line. On 3 October the company filed a DEF 14A proxy, a routine governance filing; there were no other material announcements this week.

Analyst Ratings

One covering broker rates the stock outperform, while none have buy, hold, underweight, or sell ratings; total coverage is one firm. The consensus rating is buy, with a consensus target of $16, implying 97.78% upside from the current price. Both the high and low targets sit at $16, so there is no dispersion among price views. Within its application software industry, the company ranks 160th out of 202 stocks, placing it in the lower middle of the peer set.

The Week Ahead

There are no company-specific earnings or event dates on the calendar next week, but macro data is dense. On 5 October the US S&P Global services PMI final and ISM non-manufacturing PMI land, with the ISM reading at 55.4 previously and a 55 consensus forecast. On 6 October international trade balance and goods trade balance revisions come out; on 7 October EIA weekly crude and Cushing crude inventories update. As a small-cap application software name, ReposiTrak is sensitive to rate expectations and overall risk appetite, so the macro prints feed directly into sector rotation signals next week.

In Short

ReposiTrak shares dropped 1.7% this week, while the company narrative paired improving profit with a single broker’s high target. The consensus target of $16 sits nearly double the current price, yet coverage is just one firm and the industry rank is lower middle. Revenue is still declining year over year, and management is leaning on new growth engines to counter that. Valuation sits near 19.89x P/E and 2.82x P/B, not extreme for a small-cap software name. The question ahead is not a single data point, but whether profit gains carry into the next quarter and which way risk appetite for small caps tilts as macro numbers land.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.